AMPK activation by GSK621 inhibits human melanoma cells in vitro and in vivo
- 1 November 2016
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 480 (4) , 515-521
Abstract
No abstract availableKeywords
Funding Information
- Guangzhou Medical and Health Science and Technology (20141A011072)
This publication has 28 references indexed in Scilit:
- Metformin Blocks Melanoma Invasion and Metastasis Development in AMPK/p53-Dependent MannerMolecular Cancer Therapeutics, 2013
- Myc-induced AMPK-phospho p53 pathway activates Bak to sensitize mitochondrial apoptosisProceedings of the National Academy of Sciences, 2013
- Targeting the AMP-Activated Protein Kinase for Cancer Prevention and TherapyFrontiers in Oncology, 2013
- AMP-Activated Protein Kinase: A Target for Drugs both Ancient and ModernChemistry & Biology, 2012
- Metformin inhibits melanoma development through autophagy and apoptosis mechanismsCell Death & Disease, 2011
- Phosphorylation of ULK1 (hATG1) by AMP-Activated Protein Kinase Connects Energy Sensing to MitophagyScience, 2011
- AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1Nature Cell Biology, 2011
- AICAR induces apoptosis independently of AMPK and p53 through up-regulation of the BH3-only proteins BIM and NOXA in chronic lymphocytic leukemia cellsBlood, 2010
- AMPK, the metabolic syndrome and cancerTrends in Pharmacological Sciences, 2005
- Monoclonal Antibody to Single-Stranded DNA Is a Specific and Sensitive Cellular Marker of ApoptosisExperimental Cell Research, 1996